News Headlines Article

Bill boosting FDA authority over compounding pharmacies heads to Obama
Modern Healthcare

The U.S. Senate voted Monday to strengthen the Food and Drug Administration’s authority over compounding pharmacies that produce large volumes of mixed drugs.

The president is expected to sign the legislation, which will reach his desk about a year after drugs distributed by one such compounder led to a deadly multistate meningitis outbreak.

Lauded by supporters as a bicameral and bipartisan effort, the bill would allow the FDA to follow a national standard while regulating facilities making adulterated, misbranded or unapproved products as well as establish a list of drugs that may not be compounded for safety reasons.